Robert C Blaylock
Physician in Salt Lake City, UT
License number
Utah 177516-1205
Issued Date
Nov 4, 1987
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT
Personal information
See more information about Robert C Blaylock at radaris.comName
Address
Phone
5382 W Chets Ct, Salt Lake City, UT 84120
1184 Lynnwood Dr, Orem, UT 84097
347 W 1925 N, Ogden, UT 84414
1806 Cobblestone Dr, Provo, UT 84604
2321 Stringham Ave, Salt Lake City, UT 84109
Professional information
Robert Blaylock, Salt Lake City UT
Work:
Uumc Pathology Dept
50 N Medical Dr, Salt Lake City, UT 84132
50 N Medical Dr, Salt Lake City, UT 84132
Robert C Blaylock, Salt Lake City UT
Specialties:
Pathologist
Address:
50 N Medical Dr, Salt Lake City, UT 84132
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology), American Board of Pathology Sub-certificate in Blood Banking/Transfusion Medicine (Pathology)
Dr. Robert C Blaylock, Salt Lake City UT - MD (Doctor of Medicine)
Specialties:
Blood Banking & Transfusion Medicine
Address:
University Of Utah Pulmonary
50 N Medical Dr, Salt Lake City 84132
(801) 581-7806 (Phone)
50 N Medical Dr, Salt Lake City 84132
(801) 581-7806 (Phone)
Certifications:
Blood Bank & Transfusion Medicine, 1993, Clinical Pathology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Of Utah Pulmonary
50 N Medical Dr, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Education:
Medical School
University Of Utah School Of Medicine
Graduated: 1986
University Of Ut Med Center
University Of Utah School Of Medicine
Graduated: 1986
University Of Ut Med Center
Terminally-Differentiated Anucleate Platelet Progeny Generation
US Patent:
2011029, Dec 1, 2011
Filed:
Oct 7, 2009
Appl. No.:
13/122886
Inventors:
Hansjorg Schwertz - Salt Lake City UT, US
Robert C. Blaylock - Salt Lake City UT, US
Larry W. Kraiss - Salt Lake City UT, US
Guy A. Zimmerman - Salt Lake City UT, US
Andrew S. Weyrich - Salt Lake City UT, US
Robert C. Blaylock - Salt Lake City UT, US
Larry W. Kraiss - Salt Lake City UT, US
Guy A. Zimmerman - Salt Lake City UT, US
Andrew S. Weyrich - Salt Lake City UT, US
International Classification:
A61K 38/02, A61K 31/7072, A61K 31/551, A61K 31/496, A61K 31/536, A61P 7/00, A61K 31/203, A61K 31/708, A61K 31/7068, A61K 31/513, A61K 31/52, C12N 5/078, A61K 31/505
US Classification:
514 135, 435325, 435391, 514 50, 514220, 51425309, 5142305, 514272, 514559, 514 45, 514 49, 514274, 5142634
Abstract:
Platelets are induced to proliferate, form extensions and produce daughter cells by various methods, including culturing platelets under thrombocytopenic conditions. Expansion of platelet cell numbers increases the storage life of platelets. Modulation of RT activity can be used to produce new daughter platelets. Therefore, the invention provides a new therapeutic use for RT inhibitors that can now be used for treatment of thrombocytopenia and related disorders. Likewise, application of soluble protein factor that may be secreted and/or released by platelets cultured under thrombocytopenic conditions may also be used as a therapeutic agent to increase platelet numbers.